vs
Side-by-side financial comparison of AMERISAFE INC (AMSF) and KAMADA LTD (KMDA). Click either name above to swap in a different company.
AMERISAFE INC is the larger business by last-quarter revenue ($80.1M vs $47.0M, roughly 1.7× KAMADA LTD). KAMADA LTD runs the higher net margin — 11.3% vs 10.2%, a 1.1% gap on every dollar of revenue. On growth, KAMADA LTD posted the faster year-over-year revenue change (12.6% vs 10.3%). Over the past eight quarters, KAMADA LTD's revenue compounded faster (12.0% CAGR vs 2.8%).
AMERISAFE Inc. is a specialty insurance provider that focuses exclusively on workers' compensation coverage for small and mid-sized businesses in high-hazard industries including construction, logging, trucking, and manufacturing. It operates across 49 U.S. states, offering tailored insurance policies paired with targeted risk management support for clients.
Kamada Ltd. is a global biopharmaceutical company specializing in the research, manufacturing, and commercialization of specialty pharmaceuticals derived from human plasma.
AMSF vs KMDA — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $80.1M | $47.0M |
| Net Profit | $8.1M | $5.3M |
| Gross Margin | — | 42.0% |
| Operating Margin | — | 16.6% |
| Net Margin | 10.2% | 11.3% |
| Revenue YoY | 10.3% | 12.6% |
| Net Profit YoY | -9.0% | 37.1% |
| EPS (diluted) | $0.43 | $0.09 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $80.1M | — | ||
| Q4 25 | $81.6M | — | ||
| Q3 25 | $82.0M | $47.0M | ||
| Q2 25 | $81.1M | $44.8M | ||
| Q1 25 | $72.6M | $44.0M | ||
| Q4 24 | $74.0M | — | ||
| Q3 24 | $78.7M | $41.7M | ||
| Q2 24 | $75.8M | $42.5M |
| Q1 26 | $8.1M | — | ||
| Q4 25 | $10.4M | — | ||
| Q3 25 | $13.8M | $5.3M | ||
| Q2 25 | $14.0M | $7.4M | ||
| Q1 25 | $8.9M | $4.0M | ||
| Q4 24 | $13.2M | — | ||
| Q3 24 | $14.3M | $3.9M | ||
| Q2 24 | $11.0M | $4.4M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 42.0% | ||
| Q2 25 | — | 42.3% | ||
| Q1 25 | — | 47.1% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 41.3% | ||
| Q2 24 | — | 44.6% |
| Q1 26 | — | — | ||
| Q4 25 | 15.6% | — | ||
| Q3 25 | 21.3% | 16.6% | ||
| Q2 25 | 21.5% | 15.8% | ||
| Q1 25 | 15.5% | 17.7% | ||
| Q4 24 | 22.7% | — | ||
| Q3 24 | 22.6% | 12.7% | ||
| Q2 24 | 18.1% | 13.3% |
| Q1 26 | 10.2% | — | ||
| Q4 25 | 12.8% | — | ||
| Q3 25 | 16.9% | 11.3% | ||
| Q2 25 | 17.2% | 16.5% | ||
| Q1 25 | 12.3% | 9.0% | ||
| Q4 24 | 17.8% | — | ||
| Q3 24 | 18.2% | 9.3% | ||
| Q2 24 | 14.5% | 10.4% |
| Q1 26 | $0.43 | — | ||
| Q4 25 | $0.55 | — | ||
| Q3 25 | $0.72 | $0.09 | ||
| Q2 25 | $0.73 | $0.13 | ||
| Q1 25 | $0.47 | $0.07 | ||
| Q4 24 | $0.69 | — | ||
| Q3 24 | $0.75 | $0.07 | ||
| Q2 24 | $0.57 | $0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $34.2M | $72.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $246.6M | $265.2M |
| Total Assets | — | $377.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $34.2M | — | ||
| Q4 25 | $61.9M | — | ||
| Q3 25 | $54.7M | $72.0M | ||
| Q2 25 | $48.5M | $66.0M | ||
| Q1 25 | $44.8M | $76.3M | ||
| Q4 24 | $44.1M | — | ||
| Q3 24 | $63.7M | $72.0M | ||
| Q2 24 | $30.6M | $56.5M |
| Q1 26 | $246.6M | — | ||
| Q4 25 | $251.6M | — | ||
| Q3 25 | $274.8M | $265.2M | ||
| Q2 25 | $265.6M | $260.0M | ||
| Q1 25 | $260.8M | $252.0M | ||
| Q4 24 | $257.3M | — | ||
| Q3 24 | $314.4M | $255.3M | ||
| Q2 24 | $301.0M | $251.2M |
| Q1 26 | — | — | ||
| Q4 25 | $1.1B | — | ||
| Q3 25 | $1.2B | $377.2M | ||
| Q2 25 | $1.2B | $368.2M | ||
| Q1 25 | $1.2B | $375.1M | ||
| Q4 24 | $1.2B | — | ||
| Q3 24 | $1.3B | $351.2M | ||
| Q2 24 | $1.2B | $351.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $10.4M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | 1.97× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $11.1M | — | ||
| Q3 25 | $10.7M | $10.4M | ||
| Q2 25 | $-8.4M | $8.0M | ||
| Q1 25 | $-1.8M | $-513.0K | ||
| Q4 24 | $24.2M | — | ||
| Q3 24 | $8.4M | $22.2M | ||
| Q2 24 | $-2.6M | $14.0M |
| Q1 26 | — | — | ||
| Q4 25 | $8.9M | — | ||
| Q3 25 | $9.8M | — | ||
| Q2 25 | $-9.5M | — | ||
| Q1 25 | $-1.8M | — | ||
| Q4 24 | $23.4M | — | ||
| Q3 24 | $8.4M | — | ||
| Q2 24 | $-2.6M | — |
| Q1 26 | — | — | ||
| Q4 25 | 10.9% | — | ||
| Q3 25 | 11.9% | — | ||
| Q2 25 | -11.7% | — | ||
| Q1 25 | -2.5% | — | ||
| Q4 24 | 31.5% | — | ||
| Q3 24 | 10.7% | — | ||
| Q2 24 | -3.5% | — |
| Q1 26 | — | — | ||
| Q4 25 | 2.6% | — | ||
| Q3 25 | 1.1% | — | ||
| Q2 25 | 1.3% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 1.1% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.1% | — |
| Q1 26 | — | — | ||
| Q4 25 | 1.06× | — | ||
| Q3 25 | 0.77× | 1.97× | ||
| Q2 25 | -0.61× | 1.09× | ||
| Q1 25 | -0.20× | -0.13× | ||
| Q4 24 | 1.83× | — | ||
| Q3 24 | 0.59× | 5.75× | ||
| Q2 24 | -0.24× | 3.15× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
